Bayer
Contact
Present at parks
News
Bayer to invest EUR 220 million in new R&D facility at its Monheim site
Largest single investment in Crop Protection in Germany for 40 years / Focus on Environmental and Human Safety / State-of-the-art lab building and greenhouse / 5 floor main building; 28,000 m2 gros...
WuXi Biologics and Bayer Enter into an Acquisition Agreement on a Drug Product Plant in Germany
Chempark Leverkusen Currenta →First drug product facility in Europe to complement WuXi Biologics’ existing commercial manufacturing capacities. WuXi Biologics will be the back-up manufacturer for Kovaltry™ of Bayer
Bayer CropScience invests 100 million in new herbicide production
Industriepark Höchst →With a solemn ceremony, the foundation stone was laid for the new glufosinate-ammonium plant at Höchst Industrial Park.
A new Bayer MaterialScience production line at Dormagen, Germany: the manufacture of plastics from CO2
Chempark Dormagen →Further milestone in the manufacture of plastics from CO2. Reactor in place – start of production in 2016 in Dormagen is getting closer. Company intends to replace petroleum with carbon dioxide
Bayer MaterialScience wraps up major investment in Germany
Chempark Dormagen →Company invests some EUR 250 million at Dormagen site / Foam component TDI produced in a highly resource-efficient process / Governor Kraft: Strengthening North Rhine-Westphalia as chemical industr...
Bayer MaterialScience expands technology and production
Chempark Leverkusen Currenta →Multi-million-euro investments at Leverkusen site: Ultra-modern technical center for foams / New production plant for coating raw materials commissioned
Bayer MaterialScience planning new world-scale TDI plant at Dormagen site
Chempark Dormagen →EUR 150 million investment in the future / New production process was developed in Dormagen / Energy savings of up to 60 percent versus conventional plants
Bayer MaterialScience opens world's largest carbon nanotube pilot facility
Chempark Leverkusen Currenta →Bayer MaterialScience has opened a new pilot facility for the manufacture of carbon nanotubes (CNTs) at CHEMPARK Leverkusen. The company has invested some EUR 22 million in the planning, developmen...
Linde constructs Bayer plant for production of monoethylene glycol
Chempark Dormagen →Scope: Licence, basic engineering, authority engineering, detail engineering, procurement on behalf and at account of buyer, supervision of civil work and erection
About
Bayer AG is a German management holding company with core competencies in the field of health care, nutrition and high-tech materials. It's business operations are organized into three subgroups: HealthCare, involved in the research, development and manufacture of health products for people and animals, CropScience, engaged in the crop protection and non-agricultural pest control, and MaterialScience, that provides polymers, and develops solution for a range of applications, supported by the service companies Bayer Business Services, Bayer Technology Services and Currenta. It operates through numerous subsidiaries, affiliated companies, as well as joint ventures located in Europe, Latin America, Africa, Middle East, North America, as well as the Asia/Pacific region, such as Bayer Chemicals AG in Germany, Cotton Growers Services Pty. Limited in Australia and Bayer Israel Ltd in Israel. In August 2012, its subsidiary, Bayer CropScience Ltd, completed purchase of AgraQuest Inc.